¿Û¿Û´«Ã½

Redemptions were concentrated in the fourth quarter

Management is guiding for 4-6 per cent organic revenue growth

Margin pressure may have affected investor sentiment on results day

The Irish medical supplier has initiated a €35mn share buyback programme

The group's 12-point self-help plan is producing material benefits

A summary of key company announcements expected in the coming week

The US retail giant is expanding in the face of technological change

Generics are constraining net revenue

The company flagged a weak consumer demand backdrop

Cash returns are on the rise due to a double-digit increase in operating cash flow